On Wednesday, the United States Patent and Trademark Office (USPTO) issued a Notice of Allowance for a new patent related to Anixa Biosciences, Inc.'s (NASDAQ:ANIX) breast cancer vaccine technology.
Cleveland Clinic has exclusively licensed the patent and others related to this technology to Anixa Biosciences. The patent will expand the scope of immunogenic compositions utilized in Anixa's breast cancer vaccine.
https://finance.yahoo.com/news/exclusive-anixa-biosciences-receives-key-114531091.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.